Device Trial Radar · NCT06540716
Inspire Singapore Study
Last checked: Nov 20, 2026Latest source record: May 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
44
Actual
Start
Jul 25, 2024
Primary completion
Jul 17, 2025
Study completion Dec 1, 2025
Sponsor
- Lead sponsor
- Inspire Medical Systems, Inc.Public (INSP)
- Sponsor type
- Industry
- First posted
- Aug 6, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 21 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Prospective, multicenter, open-label study designed to confirm device performance of Inspire system in Singapore.
Conditions
- Obstructive Sleep Apnea
- OSA
- Sleep Apnea
Interventions
Inspire SystemDevice
Hypoglossal nerve stimulation therapy will be activated at approximately 1 month post-implant.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Inspiratory OverlapTime frame: 0-3 months post-therapy activation
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
National University Hospital
Singapore, Singapore
Singapore General Hospital
Singapore, Singapore
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.